摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-2-cyano-3-[4-(dimethylamino)phenyl]-2-propenamide | 97006-42-3

中文名称
——
中文别名
——
英文名称
(E)-2-cyano-3-[4-(dimethylamino)phenyl]-2-propenamide
英文别名
(E)-2-cyano-3-[4-(dimethylamino)phenyl]acrylamide;2-[4-(dimethylamino)benzylidene]-2-cyanoacetamide;2-cyano-3-(N,N-dimethylaminophenyl)-2-propenamide;2-cyano-3-[4-(dimethylamino)phenyl]propenamide;p-N,N-(dimethylamino)benzylidenecyanoacetamide;2-cyano-3t-(4-dimethylamino-phenyl)-acrylic acid amide;alpha-Cyano-p-(dimethylamino)cinnamamide;(E)-2-cyano-3-[4-(dimethylamino)phenyl]prop-2-enamide
(E)-2-cyano-3-[4-(dimethylamino)phenyl]-2-propenamide化学式
CAS
97006-42-3
化学式
C12H13N3O
mdl
——
分子量
215.255
InChiKey
TVPUSDGUXXMGMH-JXMROGBWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    197 °C
  • 沸点:
    469.5±45.0 °C(Predicted)
  • 密度:
    1.203±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    70.1
  • 氢给体数:
    1
  • 氢受体数:
    3

SDS

SDS:011abb0af76d899171b1d7f3b9da84c0
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (E)-2-cyano-3-[4-(dimethylamino)phenyl]-2-propenamide 在 sodium tetrahydroborate 作用下, 以 甲醇 为溶剂, 以61%的产率得到2-cyano-3-[4-(dimethylamino)phenyl]propanamide
    参考文献:
    名称:
    Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases
    摘要:
    The 3-aryl-2-cyanoacrylamide scaffold was designed as core pharmacophore for inhibitors of the Dengue and West Nile virus serine proteases (NS2B-NS3). A total of 86 analogs was prepared to study the structure-activity relationships in detail. Thereby, it turned out that the electron density of the aryl moiety and the central double bond have a crucial influence on the activity of the compounds, whereas the influence of substituents of the amide residue is less relevant. The para-hydroxy substituted analog was found to be the most potent inhibitor in this series with a K(i)-value of 35.7 mu M at the Dengue and 44.6 mu M at the West Nile virus protease. The aprotinin competition assay demonstrates a direct interaction of the inhibitor molecule with active centre of the Dengue virus protease. The target selectivity was studied in a counterscreen with thrombin and found to be 2.8:1 in favor of DEN protease and 2.3:1 in favor of WNV protease, respectively. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2011.10.061
  • 作为产物:
    描述:
    ((4-(二甲基氨基)苯基)亚甲基)甲烷-1,1-二甲腈sodium acetate 作用下, 以 溶剂黄146 为溶剂, 反应 50.0h, 以47%的产率得到(E)-2-cyano-3-[4-(dimethylamino)phenyl]-2-propenamide
    参考文献:
    名称:
    Mishriky, Nawal; Ibrahim; Girgis, Pharmazie, 2000, vol. 55, # 4, p. 269 - 272
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • [EN] AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME<br/>[FR] AGENTS CIBLANT LES AMYLOÏDES ET PROCÉDÉS DE LEUR UTILISATION
    申请人:AMYDIS DIAGNOSTICS
    公开号:WO2015143185A1
    公开(公告)日:2015-09-24
    Provided herein is the design and synthesis of novel molecular rotor fluorophores useful for detection of amyloid or amyloid like proteins. The fluorophores are designed to exhibit enhanced fluorescence emission upon associating with amyloid or amyloid like proteins as compared to unbound compound. Also disclosed herein are the methods for treating of diseases associated with an amyloid or amyloid like proteins.
    本文提供了用于检测淀粉样蛋白或类淀粉样蛋白的新型分子转子荧光团的设计和合成。这些荧光团被设计为与淀粉样蛋白或类淀粉样蛋白结合时,与未结合化合物相比表现出增强的荧光发射。本文还披露了用于治疗与淀粉样蛋白或类淀粉样蛋白相关疾病的方法。
  • Tetra‐<i>n</i>‐butylammonium Hydroxide (TBAH)–Catalyzed Knoevenagel Condensation: A Facile Synthesis of α‐Cyanoacrylates, α‐Cyanoacrylonitriles, and α‐Cyanoacrylamides
    作者:Saeed Balalaie、Morteza Bararjanian
    DOI:10.1080/00397910500385258
    日期:2006.3.1
    Abstract Tetra‐n‐butylammonium hydroxide (TBAH) has been utilized as a novel and efficient catalyst for the Knoevenagel condensation of aldehydes with acidic methylene compounds such as methyl‐ and ethylcyanoacetate, malononitrile, and cyanoacetamide to afford substituted olefins.
    摘要 四正丁基氢氧化铵 (TBAH) 已被用作一种新型有效的催化剂,用于醛与酸性亚甲基化合物(如氰基乙酸甲酯和乙酯、丙二腈和氰基乙酰胺)的 Knoevenagel 缩合反应,得到取代的烯烃。
  • Some cyano-amides and dicyano-glutaconimides derived from pyridine aldehydes
    作者:J. S. A. Brunskill
    DOI:10.1039/p19720002946
    日期:——
    2-Cyano-3-pyridylacrylamides, 2-cyano-3-pyridylpropionamides, and salts of 3,5-dicyano-6-hydroxy-4-pyridyl-2-pyridones have been prepared from four pyridine aldehydes and tested for pharmacological and antimicrobial activity. Spectra–structure correlations include evidence that in the acrylamides the carbamoyl and pyridyl groups are trans.
    由四个吡啶醛制备了2-氰基-3-吡啶基丙烯酰胺,2-氰基-3-吡啶基丙酰胺和3,5-二氰基-6-羟基-4-吡啶基-2-吡啶酮的盐,并对其药理和抗菌活性进行了测试。 。光谱结构的相关性包括证据表明,在丙烯酰胺中,氨基甲酰基和吡啶基是反式的。
  • A study of some reactions of the intermediate isolated from the NN-dimethylaniline–tetracyanoethylene reaction
    作者:P. G. Farrell、R. K. Wojtowski
    DOI:10.1039/j39700001390
    日期:——
    It was previously suggested that the intermediate isolated from the NN-dimethylaniline–tetracyanoethylene reaction was zwitterionic. Synthetic and spectroscopic studies on this intermediate reported here indicate that a neutral substituted ethane structure is the correct one. The compounds formed by hydrolysis of the intermediate by acid and by base are described.
    以前曾有人提出,从NN-二甲基苯胺-四氰基乙烯反应中分离出的中间体是两性离子。此处报道的对该中间体的合成和光谱研究表明,中性取代的乙烷结构是正确的。描述了通过中间体被酸和碱水解形成的化合物。
  • [EN] METHODS OF DETECTING NEUROLOGICAL DISORDERS VIA BINDING TO PHOSPHORYLATED TAU PROTEIN<br/>[FR] MÉTHODES DE DÉTECTION DE TROUBLES NEUROLOGIQUES PAR LIAISON À UNE PROTÉINE TAU PHOSPHORYLÉE
    申请人:SARRAF STELLA
    公开号:WO2021055639A1
    公开(公告)日:2021-03-25
    Provided herein are methods and compositions for determining whether a patient suffers from a neurological disease or disorder is provided, comprising detecting the presence of a phosphorylated tau protein in a tissue of the patient, wherein the detecting comprises contacting the phosphorylated tau protein with a compound described herein.
    本文提供了一种确定患者是否患有神经系统疾病或紊乱的方法和组合物,包括检测患者组织中磷酸化tau蛋白的存在,其中检测包括将磷酸化tau蛋白与本文描述的化合物接触。
查看更多